Scotts Miracle-Gro Co has reported solid financial results for fiscal 2026, showcasing its ability to navigate a challenging economic landscape. The company announced its earnings for the fourth quarter and the full year ended September 30, 2026, highlighting a modest increase in net sales and improved gross margins. This performance is significant as it reflects the company's strategic focus on growth and operational efficiency.

Based in Marysville, Ohio, Scotts Miracle-Gro operates within the agricultural chemicals sector, specifically under the SIC classification of 2870. The company is publicly traded on the New York Stock Exchange under the ticker symbol SMG. Recently, it filed an 8-K form with the SEC on November 4, 2026, detailing its financial results and condition.

According to the filing, Scotts Miracle-Gro reported net sales of $3.29 billion for the fiscal year, marking a 1% increase compared to the previous year. The company's GAAP gross margin rate improved to 32.3%, while the non-GAAP adjusted gross margin rate reached 32.4%. These improvements were attributed to supply chain savings and a favorable sales mix, despite facing higher commodity and freight costs. The filing stated, "I’m pleased with our performance and financial discipline in fiscal 2026, as we delivered on all our imperatives and significantly strengthened our balance sheet," said Nate Baxter, president and CEO.

The filing also highlighted that the company's net income from continuing operations was $3.30 per diluted share, reflecting a 6% increase over the prior year. Non-GAAP adjusted earnings from continuing operations were reported at $4.48 per diluted share, an 18% improvement. Additionally, free cash flow totaled $278.4 million, and the net leverage ratio improved to 3.89x, a positive indicator of the company's financial health.

This update is likely to impact various stakeholders, including investors, employees, and customers, as it demonstrates Scotts Miracle-Gro's commitment to growth and sustainability in the agricultural chemicals market. The company's focus on enhancing its product offerings and operational efficiencies is expected to resonate well within the industry, particularly among competitors who are also navigating similar economic challenges.

Looking ahead, Scotts Miracle-Gro has expressed optimism for fiscal 2027, with plans to continue its growth trajectory. The filing does not specify any immediate next steps, but the company aims to build on its recent momentum and further advance its strategic initiatives.